comparemela.com
Home
Live Updates
Ecolab Gains After Beating Q1 Sales Expectations And Raising FY24 Outlook; Divests Surgical Segment For $950M - Ecolab (NYSE:ECL) : comparemela.com
Ecolab Gains After Beating Q1 Sales Expectations And Raising FY24 Outlook; Divests Surgical Segment For $950M - Ecolab (NYSE:ECL)
Ecolab surges post-Q1 with sales beat, raised FY24 outlook, and plans to sell surgical segment for $950M cash.
Related Keywords
Christophe Beck ,
Ecolab Inc ,
Pest Elimination ,
Global Surgical Segment ,
comparemela.com © 2020. All Rights Reserved.